The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of March 2019. This month there is one guideline that impacts upon primary care.
The Delirium: prevention, diagnosis and management guideline has been updated. It covers diagnosing and treating delirium in people aged 18 and over in hospital and in long-term residential care or a nursing home. It also covers identifying people at risk of developing delirium in these settings and preventing onset. It aims to improve diagnosis of delirium and reduce hospital stays and complications. The update removed the recommendation to use of olanzapine for the treatment of delirium in people who are distressed or considered a risk to themselves or others.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
|« Prescription Charges for 2019||Drug Safety Update - March 2019 »|